Skip to content

Validation study of the anti-fatigue effects of imidazole dipeptide for the person performing daily exercise

Validation study of the anti-fatigue effects of imidazole dipeptide for the person performing daily exercise - Validation study of the anti-fatigue effects of imidazole dipeptide

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029571
Enrollment
24
Registered
2017-10-17
Start date
2017-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Validation of the anti-fatigue effects

Interventions

Oral intake of the control product(2weeks) Oral intake of the test product(processed food containing imidazole dipeptide)(2weeks)

Sponsors

Maruha Nichiro Corporation Institute of Next Generation SMILE WINFrontier Co., Ltd. CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Male and female healthy adults from 20 to 60 years old 2)Individuals who are without chronic illness or disease under treatment 3)Individuals who obtain written consent from the person himself(herself)

Exclusion criteria

Exclusion criteria: 1)Individuals who are sensitive to test products, the others food or medicine 2)Individuals who have a habit to ingest medicine, health foods or supplements that affects research results 3)Individuals who are pregnant or planning to become pregnant, and individuals who are breastfeeding 4)Individuals who have a history of serious heart disease, hepatopathy, kidney damage and digestive organ 5)Individuals who have been pointed out in the past abnormal ECG (arrhythmia etc.) 6)Alcohol drinkers 7)Individuals whose eating habits are extremely irregular and individuals whose life rhythms are irregular 8)Individuals who have being participate in other clinical research, individuals who are planned to participate in other clinical research within 4 weeks after the end of the study, or individuals who are planned to participate in other clinical study after informed consent for the current study 9)Individuals who were judged inappropriate for the study by tennis coach

Design outcomes

Primary

MeasureTime frame
performance test (shot of tennis) 2weeks after

Secondary

MeasureTime frame
POMS2-AS "Jikaku-sho Shirabe"(Visual Analog Scale) Kinetic eyesight Pulse wave Heart rate Blood flow Pulse Oxygen saturation concentration

Countries

Japan

Contacts

Public ContactAsami Michitatsu

Maruha Nichiro Corporation Central Research Institute

a-michitatsu@maruha-nichiro.co.jp029-864-6712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026